BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Zhejiang Medicine Terminates Phase III Oncology Trial

  Zhejiang Medicine has terminated its Phase III oncology trial for oral forms of prochloridine mesylate to treat AML due to a lack of efficacy.

  December 22, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  3 Marijuana Biotech Stock Winners for 2018

  Next year should be enormously important for Canadian marijuana stocks, as the country moves forward with legalization of recreational marijuana.

  December 22, 2017

   · 

  1 min read
• 

  Deals

  Roche Does Last-Minute Christmas Shopping, Drops $1.7 Billion on San Diego Biotech

  Roche got in some last-minute Christmas shopping, shelling out $1.7B for San Diego’s Ignyta.

  December 22, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Biocon’s Biosimilar Arm May Raise $500M to Fund Clinical Development

  Biotechnology major BioCon is likely to take its group entity Biocon Biologics public and is expected to raise about $500M.

  December 22, 2017

   · 

  1 min read
• 

  Pharm Country

  9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To

  Pfizer may be the surprise strong-growth stock for next year.

  December 22, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  FDA Proposes Easing of Medical Device Malfunctioning Reporting

  The U.S. Food and Drug Administration on Friday said it plans to let medical device makers report less serious malfunctions of some devices on a quarterly basis to cut down on repeated reviews of common problems.

  December 22, 2017

   · 

  1 min read
• JHL Biotech Proposes Voluntary Delisting from Taiwan Exchange

  The biosimilar company, which has a $419M market capitalization, operates in Taiwan and Wuhan, China.

  December 22, 2017

   · 

  1 min read
• 

  Biotech Bay

  3 Hot Cancer Immunotherapies Waiting To Blast Off in 2018

  Immuno-oncology therapeutics have revolutionized certain types of cancer treatments, and they are, in many ways, as close to miracle cures as we’ve seen in decades.

  December 22, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Teva Sees Approval at Finish Line for Anti-CGRP Migraine Treatment

  With a priority review voucher in hand, Teva is expecting the FDA to rule on its new migraine treatment fremanezumab by June.

  December 22, 2017

   · 

  4 min read

   · 

  Alex Keown
• 

  Policy

  Medical Device Tax Comes Back January 1

  For the first time in years, the medical device tax will take effect Jan. 1, after Congress left town without delivering on a long-promised delay or repeal.

  December 22, 2017

   · 

  1 min read